Active Ingredient History

  • Now
Gandotinib (LY-2784544) is an experimental drug developed by Eli Lilly for treatment of cancer. It is a small molecule JAK2 inhibitor, with additional minor inhibition of STAT3.   Wikipedia

  • SMILES: Cc1cc(Nc2cc(CN3CCOCC3)c4nc(C)c(Cc5ccc(Cl)cc5F)n4n2)n[nH]1
  • Mol. Mass: 469.95
  • ALogP: 4.03
  • ChEMBL Molecule:
More Chemistry
gandotinib | ly2784544 | ly-2784544


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue